Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.23% is 389% above its 5-year average of 1.48%, near the high end of its 5-year range (-1.43%–7.23%).
59.43% above its 12-month average of 4.54%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2027 (2026-07-31): 2.01%.
RETURN ON ASSETS (ROA)
7.23%
RETURN ON ASSETS (ROA) AVG TTM
4.54%
RETURN ON ASSETS (ROA) AVG 3Y
2.50%
RETURN ON ASSETS (ROA) AVG 5Y
1.48%
RETURN ON ASSETS (ROA) AVG 10Y
4.98%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+59.43%
CURRENT VS 3Y AVG
+189.78%
CURRENT VS 5Y AVG
+388.51%
CURRENT VS 10Y AVG
+45.23%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.69%
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
+126.12%
vs the sector median at left
HealthEquity, Inc.
Market Cap
$7.65B
Return on Assets (ROA)
7.23%
TTM Avg
4.54%
3Y Avg
2.50%
5Y Avg
1.48%
Market Cap
$7.66B
Return on Assets (ROA)
13.18%
TTM Avg
-36.35%
3Y Avg
-30.02%
5Y Avg
-30.02%
Market Cap
$7.73B
Return on Assets (ROA)
-46.45%
TTM Avg
-48.58%
3Y Avg
-49.83%
5Y Avg
-41.46%
Market Cap
$7.34B
Return on Assets (ROA)
-18.86%
TTM Avg
-12.96%
3Y Avg
-12.20%
5Y Avg
-11.41%
Market Cap
$7.15B
Return on Assets (ROA)
1.51%
TTM Avg
13.71%
3Y Avg
9.00%
5Y Avg
4.65%
Market Cap
$8.43B
Return on Assets (ROA)
4.91%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$6.96B
Return on Assets (ROA)
-63.13%
TTM Avg
-53.05%
3Y Avg
-49.25%
5Y Avg
-42.24%
Market Cap
$8.68B
Return on Assets (ROA)
8.55%
TTM Avg
-64.90%
3Y Avg
-64.30%
5Y Avg
-51.23%
Market Cap
$6.71B
Return on Assets (ROA)
17.41%
TTM Avg
17.14%
3Y Avg
16.98%
5Y Avg
18.36%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthEquity, Inc. (HQY) | $7.65B | 7.23% | 4.54% | 2.50% | 1.48% |
| Hinge Health, Inc. (HNGE)vs › | $7.66B | 13.18% | -36.35% | -30.02% | -30.02% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.73B | -46.45% | -48.58% | -49.83% | -41.46% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.34B | -18.86% | -12.96% | -12.20% | -11.41% |
| Alkermes plc (ALKS)vs › | $7.15B | 1.51% | 13.71% | 9.00% | 4.65% |
| Oscar Health, Inc. (OSCR)vs › | $8.43B | 4.91% | -3.24% | -6.85% | -10.42% |
| Immunovant, Inc. (IMVT)vs › | $6.96B | -63.13% | -53.05% | -49.25% | -42.24% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.68B | 8.55% | -64.90% | -64.30% | -51.23% |
| Chemed Corporation (CHE)vs › | $6.71B | 17.41% | 17.14% | 16.98% | 18.36% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.69B | -3.91% | 11.88% | 0.12% | -6.73% |
ROA
7.2%
ROE
11.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-01-31 | 6.27% |
| 2025-01-31 | 2.80% |
| 2024-01-31 | 1.76% |
| 2023-01-31 | -0.85% |
| 2022-01-31 | -1.43% |
| 2021-01-31 | 0.33% |
| 2020-01-31 | 1.55% |
| 2019-01-31 | 14.49% |
| 2018-01-31 | 12.83% |
| 2017-01-31 | 9.45% |
| 2016-01-31 | 7.56% |
| 2015-01-31 | 6.40% |
| 2014-01-31 | 2.24% |
| 2013-01-31 | 24.12% |
